• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Brigitte C. Madrian, PhD

Latest:

Testimonials Do Not Convert Patients From Brand to Generic Medication

We conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.




Sara C. Erickson, PharmD

Latest:

Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate

We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.


Jacob Reider, MD

Latest:

The Health Information Technology Special Issue: Has IT Become a Mandatory Part of Health and Healthcare?

The 7th annual Health Information Technology (IT) issue provides a window into how health IT tools are working well, how they may not be working as intended, and what we can do to continue making progress toward optimal use of technology to accomplish our shared goals: better health, better care experience, and lower per capita cost.


Michael Curry, MD

Latest:

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.


Brian Chen, JD, PhD

Latest:

Imposing a Health Insurance Surcharge on the Unvaccinated

Imposing a surcharge on unvaccinated employees will require employers to think through legal and policy implications.





Lisa A. Simpson, MB, BCh, MPH, FAAP

Latest:

That Was Then, This Is Now

When Aligning Forces started, federal policy was a desert. Now it's a greenhouse.


Robert J. LoCasale, PhD

Latest:

Treatment Patterns, Healthcare Utilization, and Costs of Chronic Opioid Treatment for Non-Cancer Pain in the United States

Healthcare utilization and costs increased in the 6 months after patients started opioid therapy for chronic pain; they then decreased but never reverted to baseline levels.




Sara N. Bleich, PhD

Latest:

Validating the Adapted Diabetes Complications Severity Index in Claims Data

The aDCSI without the inclusion of laboratory data performs similarly to the DCSI with laboratory results, and is a good measure of diabetes severity.




Rachel O. Reid, MD, MS

Latest:

Do Localized Disasters Impact Clinical Measures of Health Care Quality?

This study examines the impact of geographically limited disasters on health care quality performance scores of Medicare Advantage contracts, finding limited impact on performance scores.



Anne C. Moorman, BSN, MPH

Latest:

Hepatitis B Virus Infection Testing and Prevalence Among Asian and Pacific Islanders

We examined the effect of country of origin on HBV testing and chronic HBV infection prevalence among APIs using data from Kaiser Permanente Hawaii.


Sai Ma, PhD

Latest:

Insurers’ Perspectives on MA Value-Based Insurance Design Model

This article describes perspectives of Medicare Advantage (MA) insurers about participating in the CMS value-based insurance design model test launched in 2017.


David Newman, JD, PhD

Latest:

Overcoming Barriers to a Research-Ready National Commercial Claims Database

Lessons learned about data governance and distribution from a voluntary healthcare claims repository, the Health Care Cost Institute, a nonprofit research organization


Marlon P. Mundt, PhD

Latest:

Putting the Pieces Together: EHR Communication and Diabetes Patient Outcomes

More frequent electronic health record (EHR) message forwarding in primary care teams is associated with worse outcomes and higher medical costs for patients with diabetes.


Stefan Vegter, PharmD

Latest:

Compliance, Persistence, and Switching Patterns for ACE Inhibitors and ARBs

This drug-utilization study in a prescription database of more than 50,000 patients analyzed compliance, persistence, and switching behavior for ACE inhibitors and ARBs.



Dan Patrick

Latest:

A Medicare Appeal for CGM Coverage: One Patient's Never-Ending Story

The author, who has lived with type 1 diabetes for more than 50 years, shares his account of a successful appeal of Medicare's policy of refusing to pay for continuous glucose monitoring (CGM).



Avivit Golan-Cohen, MD

Latest:

Changing Electronic Formats Is Associated With Changes in Number of Laboratory Tests Ordered

A slight decrease in the convenience of ordering a laboratory test led to a dramatic decrease in test utilization.



© 2025 MJH Life Sciences
AJMC®
All rights reserved.